The support is designed to speed development of well-matched H5N1 vaccines and pave the way for vaccines against other ...

In this study, the authors estimated that Paxlovid reduced the risk of hospitalization by 39% (95% confidence interval [CI], 36% to 41%), with an absolute risk reduction of 0.9 percentage points. The ...

In a move that could have a significant impact on US and global efforts to monitor and respond to infectious diseases, the Trump administration yesterday said it will withdraw from the World Health ...

Yesterday the World Health Organization (WHO) said Tanzania has 1 confirmed case of Marburg and 25 suspected cases all from ...

A study published yesterday in JAMA Network Open suggests that 70.4% of nearly 850,000 US household COVID-19 transmissions originated with a child. A team led by Boston Children's Hospital researchers ...

Today the Centers for Disease Control and Prevention (CDC) in its weekly FluView update, confirmed 11 new pediatric deaths ...

Four countries reported new polio cases this week, with onsets in late 2024, according to the weekly update from the Global ...

Shionogi will receive $375 million to develop a long-acting protease inhibitor designed to prevent SARS-CoV-2 infection in ...

Dihydroartemisinin-piperaquine and sulfadoxine-pyrimethamine combined with amodiaquine reduced malaria incidence by 94% and ...

In Science of the Total Environment, a University of Surrey–led research team that measured indoor air quality (IAQ) on board ...

Kaseya said the mpox vaccine has been well received in countries that have deployed the vaccine, including in the DRC. He ...

Of more than 2,600 US healthcare workers who participated in a nationwide online panel survey from 2022 to 2023, 26% reported ...